BRAFTOVI ENCORAFENIB CAPSULES - Trademark Details
Status: 700 - Registered
Image for trademark with serial number 87756187
Serial Number
87756187
Registration Number
5625743
Word Mark
BRAFTOVI ENCORAFENIB CAPSULES
Status
700 - Registered
Status Date
2018-12-11
Filing Date
2018-01-16
Registration Number
5625743
Registration Date
2018-12-11
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
261901 - Spheres.
Published for Opposition Date
2018-09-25
Attorney Name
Heather A. McDonald
Law Office Assigned Location Code
M30
Employee Name
TAYLOR, DAVID T
Statements
Amendment to a Registration/Renewal Certificate
In the statement, Column 2, lines 4-22, " Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; for the prevention and and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma " is deleted.
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"CAPSULES" AND "ENCORAFENIB"
Description of Mark
The mark consists of three sphere designs diagonally above the word "BRAFTOVI" over the words encorafenib capsules, wherein the term encorafenib is in parentheses.
Goods and Services
[ Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use;] Pharmaceutical products for the [ prevention and ] treatment of cancer [ and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma ]
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2018-01-28
Primary Code
005
First Use Anywhere Date
2018-07-02
First Use In Commerce Date
2018-07-02
Current Trademark Owners
Party Name
Array Biopharma Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Array Biopharma Inc.
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Array Biopharma Inc.
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Array Biopharma Inc.
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Heather A. McDonald
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0077488
Original Filing Date USPTO
2018-07-16
International Registration Number
1428133
International Registration Date
2018-07-16
International Status Code
480
International Renewal Date
2028-07-16
Madrid History Events
DateCodeDescription
2018-07-19MCERTMANUALLY CERTIFIED
2018-07-19APPSTIR CERTIFIED AND SENT TO IB
2019-03-11CBPCPPARTIAL CEASING OF EFFECT TO BE PROCESSED
2021-10-29PCBNPPARTIAL CEASING OF EFFECT PROCESSED BY IB
2021-08-16CBPCPPARTIAL CEASING OF EFFECT TO BE PROCESSED
2021-08-30CBMPPCEASING OF EFFECT PROCESSED
2021-08-30CBPSPPARTIAL CEASING OF EFFECT NOTICE SENT TO IB
2019-03-21CBNARCEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE
2018-10-11CREATAPPLICATION FOR IR REGISTERED BY IB
2018-07-16NEWAPNEW APPLICATION FOR IR RECEIVED
Trademark Events
Event DateEvent Description
2018-01-19NEW APPLICATION ENTERED IN TRAM
2018-01-28NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2018-01-30NOTICE OF DESIGN SEARCH CODE E-MAILED
2018-04-26ASSIGNED TO EXAMINER
2018-05-03NON-FINAL ACTION WRITTEN
2018-05-03NON-FINAL ACTION E-MAILED
2018-05-03NOTIFICATION OF NON-FINAL ACTION E-MAILED
2018-07-10TEAS AMENDMENT OF USE RECEIVED
2018-07-11USE AMENDMENT FILED
2018-07-11AMENDMENT TO USE PROCESSING COMPLETE
2018-07-12USE AMENDMENT ACCEPTED
2018-07-13NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
2018-08-09EXAMINERS AMENDMENT -WRITTEN
2018-08-09EXAMINERS AMENDMENT E-MAILED
2018-08-09NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2018-08-09EXAMINER'S AMENDMENT ENTERED
2018-08-09APPROVED FOR PUB - PRINCIPAL REGISTER
2018-08-21ASSIGNED TO LIE
2018-09-05NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2018-09-25PUBLISHED FOR OPPOSITION
2018-09-25OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2018-12-11REGISTERED-PRINCIPAL REGISTER
2020-06-04TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-06-04TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-06-04ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-06-04TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-06-04APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-07-16TEAS SECTION 7 REQUEST RECEIVED
2020-11-16CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2020-11-16AMENDMENT UNDER SECTION 7 ¿ PROCESSED